Buisson C - Search Results

1

A role for metabolomics in the antidoping toolbox?

Narduzzi L, Dervilly G, Audran M, Le Bizec B, Buisson C. Narduzzi L, et al. Among authors: buisson c. Drug Test Anal. 2020 Jun;12(6):677-690. doi: 10.1002/dta.2788. Epub 2020 Mar 20. Drug Test Anal. 2020. PMID: 32144900 Review.

2

Metabolic and isotopic signature of short-term DHEA administration in women: Comparison with findings in men.

Buisson C, Frelat C, Privat K, Martinat N, Audran M, Collomp K. Buisson C, et al. Drug Test Anal. 2018 Nov;10(11-12):1744-1754. doi: 10.1002/dta.2519. Epub 2018 Nov 4. Drug Test Anal. 2018. PMID: 30315670

3

Applying metabolomics to detect growth hormone administration in athletes: Proof of concept.

Narduzzi L, Dervilly G, Marchand A, Audran M, Le Bizec B, Buisson C. Narduzzi L, et al. Among authors: buisson c. Drug Test Anal. 2020 Jul;12(7):887-899. doi: 10.1002/dta.2798. Epub 2020 Apr 19. Drug Test Anal. 2020. PMID: 32246894

4

Implementation of AICAR analysis by GC-C-IRMS for anti-doping purposes.

Buisson C, Frelat C, Mongongu C, Martinat N, Audran M. Buisson C, et al. Drug Test Anal. 2017 Nov;9(11-12):1704-1712. doi: 10.1002/dta.2322. Epub 2017 Nov 17. Drug Test Anal. 2017. PMID: 29032594

5

Ammonium Fluoride as Suitable Additive for HILIC-Based LC-HRMS Metabolomics.

Narduzzi L, Royer AL, Bichon E, Guitton Y, Buisson C, Le Bizec B, Dervilly-Pinel G. Narduzzi L, et al. Among authors: buisson c. Metabolites. 2019 Nov 27;9(12):292. doi: 10.3390/metabo9120292. Metabolites. 2019. PMID: 31783638 Free PMC article.

6

Coupling Complete Blood Count and Steroidomics to Track Low Doses Administration of Recombinant Growth Hormone: An Anti-Doping Perspective.

Narduzzi L, Buisson C, Morvan ML, Marchand A, Audran M, Le Bouc Y, Varlet-Marie E, Ericsson M, Le Bizec B, Dervilly G. Narduzzi L, et al. Among authors: buisson c. Front Mol Biosci. 2021 Jun 10;8:683675. doi: 10.3389/fmolb.2021.683675. eCollection 2021. Front Mol Biosci. 2021. PMID: 34179089 Free PMC article.

7

Detection of LongR³ -IGF-I, Des(1-3)-IGF-I, and R³ -IGF-I using immunopurification and high resolution mass spectrometry for antidoping purposes.

Mongongu C, Coudoré F, Domergue V, Ericsson M, Buisson C, Marchand A. Mongongu C, et al. Among authors: buisson c. Drug Test Anal. 2021 Jul;13(7):1256-1269. doi: 10.1002/dta.3016. Epub 2021 Feb 22. Drug Test Anal. 2021. PMID: 33587816

8

Report on an anti-doping operation in Guadeloupe: High number of positive cases and inferences about doping habits.

Marchand A, Buisson C, Martin L, Martin JA, Molina A, Ressiot D. Marchand A, et al. Among authors: buisson c. Drug Test Anal. 2017 Nov;9(11-12):1753-1761. doi: 10.1002/dta.2185. Epub 2017 May 24. Drug Test Anal. 2017. PMID: 28296276

9

Mass spectrometric characterization of the hypoxia-inducible factor (HIF) stabilizer drug candidate BAY 85-3934 (molidustat) and its glucuronidated metabolite BAY-348, and their implementation into routine doping controls.

Dib J, Mongongu C, Buisson C, Molina A, Schänzer W, Thuss U, Thevis M. Dib J, et al. Among authors: buisson c. Drug Test Anal. 2017 Jan;9(1):61-67. doi: 10.1002/dta.2011. Epub 2016 Jun 27. Drug Test Anal. 2017. PMID: 27346747

10

Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender.

Collomp K, Buisson C, Gravisse N, Belgherbi S, Labsy Z, Do MC, Gagey O, Dufay S, Vibarel-Rebot N, Audran M. Collomp K, et al. Among authors: buisson c. Endocrine. 2018 Mar;59(3):538-546. doi: 10.1007/s12020-017-1514-z. Epub 2018 Jan 10. Endocrine. 2018. PMID: 29322301 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters